LINC02205

Across TCGA pan-cancer cohorts, LINC02205 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated LINC02205 data layer.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where higher LINC02205 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02205 expression acts as an unfavorable survival marker, although some lineages such as CHOL and ESCA show a favorable association.

PAAD, LUSC, and HNSC are the cancer types where LINC02205 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PAAD	OS	Median	All	0.284	0.463	.006	33	view →
LUSC	OS	Tertile	All	0.242	0.440	<.001	27	view →
HNSC	DFS	Tertile	IV	0.441	0.579	.018	23	view →
COAD	DFS	Tertile	IV	0.184	0.501	.022	18	view →
LUAD	OS	Quartile	II,III,IV	0.590	0.794	.003	17	view →
UCEC	DFS	Tertile	All	0.782	0.850	.029	12	view →
THYM	DFS	Tertile	II,III,IV	0.594	0.902	.016	9	view →
CHOL	DFS	Tertile	III,IV	1.000	0.182	.034	9	view →
LGG	DFS	Tertile	All	0.163	0.408	.009	9	view →
BRCA	OS	Tertile	III,IV	0.312	0.572	.008	6	view →
BLCA	DFS	Tertile	All	0.540	0.632	.049	3	view →
STAD	OS	Quartile	IV	0.190	0.584	.003	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

LINC02205–PAAD (OS)

Open the PAAD breakdown →